Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 43 (1) , 24-30
- https://doi.org/10.1067/mjd.2000.104680
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging studyJournal of Dermatological Treatment, 1998
- The impact of chronic urticaria on the quality of lifeBritish Journal of Dermatology, 1997
- The Pathogenesis of Urticaria.The Keio Journal of Medicine, 1997
- Clinical comparison of histamine H1–receptor antagonist drugsJournal of Allergy and Clinical Immunology, 1996
- Update on Urticaria and Angioedema (Hives)Allergy and Asthma Proceedings, 1995
- Chronic UrticariaNew England Journal of Medicine, 1995
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993
- Urticaria: Current therapyJournal of Allergy and Clinical Immunology, 1990